Ledger.Open graph →

SEC Form D · filed May 28, 2020

INVO Bioscience, Inc

Offering

$3.5M

Sold

$2.1M

Exemption

Rule 506(b)

Industry

Other Health Care

Location

SARASOTA, FL

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Kevin Doody · Sarasota, FLDirector Kathleen T. Karloff · Sarasota, FLDirector Trent Davis · Sarasota, FLDirector Steven Shum · Sarasota, FLExec · Director Debra T. Hoopes · Sarasota, FLExec Michael J. Campbell · Sarasota, FLExec · Director Sandeep Soni · New York, NYDirector Harry Demott · New York, NYExec Adrian Waters · Dublin 2, IrelandDirector David Andonian · New York, NYExec · Director Neil Asinger · New York, NYDirector David E. Kass · Columbus, OHExec · Director Brett Paulk · Tomball, TXExec · Director Curtis Haines · Tomball, TXDirector Rob Ball · Grand Rapids, MIDirector R. S. Churchill · Grand Rapids, MIExec John Galdieri Iii · ANNAPOLIS, MDExec · Director Patrick Britton-Harr · ANNAPOLIS, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗